Show simple item record

dc.contributor.authorNam, Kevin
dc.contributor.authorLarholt, Kay
dc.contributor.authorHirsch, Gigi
dc.contributor.authorBeninger, Paul
dc.contributor.authorFritsche, David
dc.contributor.authorShoda, Diane
dc.contributor.authorFerguson, John
dc.contributor.authorBourgeois, Florence T.
dc.contributor.authorPalmer, Donna
dc.contributor.authorKatz, Karen
dc.contributor.authorCourtney, Matt W.
dc.date.accessioned2022-05-18T15:34:07Z
dc.date.available2021-09-20T17:30:39Z
dc.date.available2022-05-18T15:34:07Z
dc.date.issued2020-10
dc.date.submitted2020-05
dc.identifier.issn2168-4790
dc.identifier.issn2168-4804
dc.identifier.urihttps://hdl.handle.net/1721.1/131855.2
dc.description.abstractAbstract Background Data sharing among stakeholders in the development, access, and use of drug therapies is critical but the current system and process are inefficient. Methods We take a Systems Engineering approach with a realistic use case to propose a scalable design for multi-stakeholder data sharing. Results We make three major contributions to the drug development and healthcare communities: first, a methodology for developing a multi-stakeholder data sharing system, with its focus on high-level requirements that influence the design of the system architecture and technology choice; second, the development of a realistic use case for long-term patient and therapy data tracking and sharing in the use of potentially curative and durable gene and cell therapies. Further, a bridge for the ‘awareness gap’ was found between the payer (Payer is organization which takes care of financial and operational aspects (which include insurance plans, provider network) of providing health care to US citizens. Or refer to health care insurers.) and the regulator communities by illustrating the common data tracking needs, which highlights the need for coordinated data activities; and third, a proposed system architecture for scalable, multi-stakeholder data sharing. Next steps are briefly discussed. Conclusion We present a system design for multiple stakeholders such as the payer, the regulator, the developer (drug manufacturer), and the healthcare provider to share data for their decision-making. The stakeholder community would benefit from collaboratively moving the system development proposal forward for efficient and cost-effective data sharing.en_US
dc.publisherSpringer Science and Business Media LLCen_US
dc.relation.isversionofhttps://doi.org/10.1007/s43441-020-00227-yen_US
dc.rightsCreative Commons Attributionen_US
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/en_US
dc.sourceSpringer International Publishingen_US
dc.titleDynamic Dossier in the Cloud: A Sociotechnical Architecture for a Real-Time and Metrics-Based Data Tracking System with Gene and Cell Therapies as a Case Studyen_US
dc.typeArticleen_US
dc.contributor.departmentLincoln Laboratory
dc.contributor.departmentMassachusetts Institute of Technology. Center for Biomedical Innovation
dc.relation.journalTherapeutic Innovation & Regulatory Scienceen_US
dc.eprint.versionFinal published versionen_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dc.date.updated2020-11-01T04:32:28Z
dc.language.rfc3066en
dc.rights.holderThe Author(s)
dspace.embargo.termsN
dspace.date.submission2020-11-01T04:32:28Z
mit.journal.volume55en_US
mit.journal.issue2en_US
mit.metadata.statusAuthority Work Neededen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

VersionItemDateSummary

*Selected version